Sarepta Therapeutics(SRPT)
Sarepta Therapeutics, Inc. (Nasdaq: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of the end of 2019, the company has two approved drugs (see the Products section below).
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Amondys | Casimersen | 2021-02-25 | 2025-2030 | |
| Exondys | Eteplirsen | 2016-09-19 | 2025-2034 | |
| Vyondys | Golodirsen | 2019-12-12 | 2025 | |
| Elevidys | Delandistrogene moxeparvovec | 2023-06-22 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use